07.01.04
Results of a double-blind, placebo-controlled, randomized clinical study showed that daily supplementation with Nutrition 21’s Diachrome™, a patented nutritional supplement composed of Chromax® chromium picolinate and biotin, improved coronary risk factors in people with type 2 diabetes. The clinical study, which evaluated 24 patients over 30 days, was presented at the American Heart Association’s Annual Conference on Arteriosclerosis, Thrombosis & Vascular Biology (ATVB). In subjects who added Diachrome to their treatment regimen, total cholesterol levels dropped an average of 19.1 mg/dL; LDL cholesterol levels dropped an average of 10.9 mg/dL; average fasting blood glucose (FBG) levels decreased 26.2 mg/dL; apo-B dropped –5.3 mg/dL and the ratio of apo-B/apo-A to LDL-C/HDL-C improved. All study subjects had type 2 diabetes for at least one year.